NF-M trans-activates the human DNA topoisomerase IIα promoter independently of c-Myb in HL-60 cells

Leukemia Research

Volumn 21, Issue 8, 1997, Pages 711-720

  Brandt, Tessa L ^a   Kroll, David J ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

c Myb; C EBP family; Cancer chemotherapy; DNA topoisomerases; HL 60 cells; Transcriptional activation

Indexed keywords

ANTINEOPLASTIC AGENT; BUTYRIC ACID; DNA TOPOISOMERASE (ATP HYDROLYSING); PROTEIN NF M; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DNA TRANSFECTION; DRUG RESISTANCE; ELECTROPORATION; GENE INDUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIGENE FAMILY; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, NEOPLASM; CCAAT-ENHANCER-BINDING PROTEINS; COS CELLS; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HL-60 CELLS; HUMANS; ISOENZYMES; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0030722608     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00040-4     Document Type: Article

References (50)

1. Osheroff, N., Zechiedrich, E. L. and Gale, K. C., Catalytic function of DNA topoisomerase II. BioEssays, 1991, 13, 269-275.
2. Watt, P. M. and Hickson, I. D., Structure and function of type II DNA topoisomerases. Biochemistry Journal, 1994, 303, 681-695.
3. Wang, J. C., Recent studies of DNA topoisomerases. Biochimica et Biophysica Acta, 1987, 909, 1-9.
4. Nelson, W. G., Liu, L. F. and Coffey, D. S., Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature, 1986, 322, 187-189.
5. Qiu, J., Catapano, C. V. and Fernandes, D. J., Formation of topoisomerase IIα complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry, 1996, 35, 16354-16360.
6. Holm, C., Goto, T., Wang, J. C. and Botstein, D., DNA topoisomerase II is required at the time of mitosis in yeast. Cell, 1985, 41, 553-563.
7. Holm, C., Stearns, T. and Botstein, D., DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Molecular and Cellular Biology, 1989, 9, 159-168.
8. Uemura, T., Ohkura, H., Adachi, Y., Morino, K., Shiozaki, K. and Yanagida, M., DNA topoisomerase is required for condensation and separation of mitotic chromosomes in S. pombe. Cell, 1987, 50, 917-925.
9. Roca, J., Berger, J. M., Harrison, S. C. and Wang, J. C., DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. Proceedings of the National Academy of Science of the U.S.A., 1996, 93, 4057-4062.
10. Chen, A. Y. and Liu, L. F., DNA Topoisomerases: Essential enzymes and lethal targets. Annual Review in Pharmacology and Toxicology, 1994, 34, 191-218.
11. Kaufmann, S. H., Karp, J. E., Jones, R. J., Miller, C. B., Schneider, E., Zwelling, L. A., Cowan, K., Wendel, K. and Burke, P. J., Topoisomerase II levels and drug sensitivity in adult myelogenous leukemia. Blood, 1994, 83, 517-530.
12. Nelson, E. M., Tewey, K. M. and Liu, L. F., Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-anisidide. Proceedings of the National Academy of Science of the U.S.A., 1984, 81, 1361-1365.
13. Chow, K. C., King, C. K. and Ross, W. E., Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochemical Pharmacology, 1988, 37, 1117-1122.
14. Kamesaki, S., Kamesaki, H., Jorgensen, T. J., Tanizawa, A., Pommier, Y. and Cossman, J., Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on event subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Research, 1993, 53, 4251-4256.
15. Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. M., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C. M. and Wang, J. C., Cloning and sequencing of cDNA encoding human topoisomerase II and localization to chromosome region 17q21-22. Proceedings of the National Academy of Science of the U.S.A., 1988, 85, 7177-7181.
16. Jenkins, J. R., Ayton, P., Jones, T., Davies, S. L., Simmons, D. L., Harris, A. L., Sheer, D. and Hickson, I. D., Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Research, 1992, 20, 5587-5592.
17. Jensen, S., Redwood, C. S., Jenkins, J. R., Andersen, A. H. and Hickson, I. D., Human DNA topoisomerases IIa and IIβ can functionally substitute for yeast TOP2 in chromosome segregation and recombination. Molecular and Genetical Genetics, 1996, 252, 79-86.
18. Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T. and Mirabelli, C. K., Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 1989, 28, 8154-8160.
19. Fernandas, D. J., Qiu, J. and Catapano, C. V., DNA topoisomerase II isozymes involved in anticancer drug action and resistance. Advances in Enzyme Regulation, 1995, 35, 265-281.
20. Kaufmann, S. H., McLaughlin, S. J., Kastan, M. B., Liu, L. F., Karp, J. E. and Burke, P. J., Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Research, 1991, 51, 3534-3543.
21. Hsiang, Y.-H., Wu, H. and Liu, L. F., Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Research, 1988, 48, 3230-3235.
22. Nelson, W. G., Cho, K. R., Hsiang, Y.-H., Liu, L. F. and Coffey, D. S., Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas. Cancer Research, 1987, 47, 3246-3250.
23. Sullivan, D. M., Latham, M. D. and Ross, W. E., Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Cancer Research, 1987, 47, 3973-3979.
24. Daev, E., Chaly, N., Brown, D. L., Valentine, B., Little, J. E., Chen, X. and Walker, P. R., Role of topoisomerase II in the structural and functional evolution of mitogen-stimulated lymphocyte nuclei. Experimental Cell Research, 1994, 214, 331-342.
25. Woessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K. and Drake, F. H., Proliferation-and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differentiation, 1991, 2, 209-214.
26. Kimura, K., Saijo, M., Ui, M. and Enomoto, T., Growth state-and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase. Journal of Biological Chemistry, 1994, 269, 1173-1176.
27. Webb, C. D., Latham, M. D., Lock, R. B. and Sullivan, D. M., Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Research, 1991, 51, 6543-6549.
28. Kubo, T., Kohno, K., Ohga, T., Taniguchi, K., Kawanami, K., Wada, M. and Kuwano, M., DNA topoisomerase IIα gene expression under transcriptional control in etoposide/ teniposide-resistant human cancer cells. Cancer Research, 1995, 55, 3860-3864.
29. Hochhauser, D., Stanway, C. A., Harris, A. L. and Hickson, I. D., Cloning and characterization of the 5′-flanking region of the human topoisomerase IIα gene. Journal of Biological Chemistry, 1992, 267, 18961-18965.
30. Birnie, G. D., The HL-60 cell line: a model system for studying human myeloid cell differentiation. British Journal of Cancer, 1988, 9, 41-45.
31. Fraser, D. J., Brandt, T. L. and Kroll, D. J., Topoisomerase IIα promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells. Molecular Pharmacology, 1995, 47, 696-706.
32. Brandt, T. L., Fraser, D. J., Leal, S., Halandras, P. M., Kroll, A. R. and Kroll, D. J., c-Myb trans-activates the human DNA topoisomerase IIα gene. Journal of Biological Chemistry, 1997, 272, 6278-6284.
33. Duprey, S. P. and Boettiger, D., Developmental regulation of c-myb in normal myeloid progenitor cells. Proceedings of the National Academy of Science of the U.S.A., 1985, 82, 6937-6941.
34. Todokoro, K., Watson, R. J., Higo, H., Amanuma, H., Kuramochi, S., Yanagisawa, H. and Ikawa, Y., Downregulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proceedings of the National Academy of Science of the U.S.A., 1988, 85, 8900-8904.
35. Yamada, K., Tsuchiya, M., Mishima, K. and Shimoyama, M., p33, an endogenous target protein for arginine-specific ADP-ribosyltransferase in chicken polymorphonuclear leukocytes, is highly homologous to mim-1 protein (myb-induced myeloid protein-1). FEBS Letters, 1992, 311, 203-205.
36. Ness, S. A., Kowenz-Leutz, E., Casini, T., Graf, T. and Leutz, A., Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Development, 1993, 7, 749-759.
37. Katz, S., Kowenz-Leutz, E., Müller, C., Meese, K., Ness, S. A. and Leutz, A., The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO Journal, 1993, 12, 1321-1332.
38. Dudek, H., Tantravahi, R. V., Rao, V. N., Reddy, E. S. P. and Reddy, E. P., Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proceedings of the National Academy of Science of the U.S.A., 1992, 89, 1291-1295.
39. Pope, R. M., Leutz, A. and Ness, S. A., C/EBPβ regulation of the tumor necrosis factor a gene. Journal of Clinical Investigation, 1994, 94, 1449-1455.
40. Badiani, P., Corbella, P., Kioussis, D., Marvel, J. and Weston, K., Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Development, 1994, 8, 770-782.
41. Sambrook, J., Fritsch, E. F., and Maniatis, T., Molecular cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
42. Oelgeschläger, M., Janknecht, R., Krieg, J., Schreek, S. and Lüscher, B., Interaction of the co-activator CBP with Myb and proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO Journal, 1996, 15, 2771-2780.
43. Burk, O., Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO Journal, 1993, 12, 2027-2038.
44. Dai, P., Akimaru, H., Tanaka, Y., Hou, D., Yasukawa, T., Kanei-Ishii, C., Takahashi, T. and Ishii, S., CBP as a transcriptional coactivator of c-Myb. Genes Development, 1996, 10, 528-540.
45. Dash, A. B., Orrico, F. C. and Ness, S. A., The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Development, 1996, 10, 1858-1869.
46. Shapiro, L. H., Myb and Ets proteins cooperate to transactivate an early myeloid gene. Journal of Biological Chemistry, 1995, 270, 8763-8771.
47. Favier, D. and Gonda, T. J., Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene, 1994, 9, 305-311.
48. Yang, X.-J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. and Nakatani, Y., A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature, 1996, 382, 319-324.
49. Bannister, A. J. and Kouzarides, T., The CBP co-activator is a histone acetyltransferase. Nature, 1996, 384, 641-643.
50. Boffa, L. C., Vidali, G., Mann, R. S. and Allfrey, V. G., Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. Journal of Biological Chemistry, 1978, 253, 3364-3366.